UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
||
| For the quarterly period ended June 30, 2002 | |||
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
||
| For the transition period from ________ to ________ . | |||
| Commission file number 000-23783 | |||
| MICROMUSE INC. (Exact name of registrant as specified in its charter) | |||
| DELAWARE | 94-3288385 |
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
139 TOWNSEND STREET
SAN FRANCISCO, CALIFORNIA 94107
(415) 538-9090
(Address, including ZIP
code, and telephone number)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o
74,737,662 shares of Common Stock, $0.01 par value, were outstanding as of July 31, 2002.
MICROMUSE INC.
TABLE OF CONTENTS
2
Part I FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
MICROMUSE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)
| ASSETS | |||||||
| June 30, | September 30, | ||||||
| 2002 | 2001 | ||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 110,672 | $ | 138,581 | |||
| Short-term investments | 35,702 | 16,109 | |||||
| Billed receivables, net | 23,175 | 31,067 | |||||
| Prepaid expenses and other current assets | 10,306 | 15,656 | |||||
| Total current assets | 179,855 | 201,413 | |||||
| Property and equipment, net | 11,025 | 15,221 | |||||
| Long-term investments | 47,982 | 20,891 | |||||
| Goodwill and other intangible assets, net | 27,809 | 36,113 | |||||
| $ | 266,671 | $ | 273,638 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 1,265 | $ | 5,686 | |||
| Accrued expenses | 15,891 | 27,407 | |||||
| Income taxes payable | 6,153 | 6,152 | |||||
| Deferred revenue | 38,872 | 34,212 | |||||
| Total current liabilities | 62,181 | 73,457 | |||||
| Stockholders' equity | |||||||
| Preferred stock; $0.01 par value; 5,000 shares authorized; | |||||||
| no shares issued and outstanding | - | - | |||||
| Common stock; $0.01 par value; 200,000 shares authorized; | |||||||
| 74,730 and 73,903 shares outstanding as of June 30, | |||||||
| 2002 and September 30, 2001, respectively | 747 | 739 | |||||
| Additional paidin capital | 192,862 | 187,755 | |||||
| Treasury stock | (2,657 | ) | (2,657 | ) | |||
| Accumulated other comprehensive loss | (2,179 | ) | (1,317 | ) | |||
| Retained earnings | 15,717 | 15,661 | |||||
| Total stockholders' equity | 204,490 | 200,181 | |||||
| $ | 266,671 | $ | 273,638 | ||||
| See accompanying notes to the condensed consolidated financial statements | |||||||
3
4
MICROMUSE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
| Nine months ended | |||||||
| June 30, | |||||||
| 2002 | 2001 | ||||||
| Cash flows from operating activities: | |||||||
| Net income | $ | 56 | $ | 20,293 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 15,089 | 13,032 | |||||
| Amortization of deferred employee compensation | - | 42 | |||||
| Compensation expense related to issuance of warrant | 170 | - | |||||
| Tax benefit related to exercise of stock options | 56 | 2,728 | |||||
| Deferred income taxes | - | 2,100 | |||||
| Changes in operating assets and liabilities: | |||||||
| Billed receivables, net | 8,207 | (16,170 | ) | ||||
| Prepaid expenses and other current assets | 5,550 | (3,086 | ) | ||||
| Accounts payable | (4,430 | ) | 1,802 | ||||
| Accrued expenses | (11,628 | ) | 16,182 | ||||
| Income taxes payable | (13 | ) | 4,601 | ||||
| Deferred revenue | 4,226 | 11,830 | |||||
| Net cash provided by operating activities | 17,283 | 53,354 | |||||
| Cash flows from investing activities: | |||||||
| Capital expenditures | (2,450 | ) | (9,455 | ) | |||
| Investment purchases, net | (46,685 | ) | (32,211 | ) | |||
| Cash used in investing activities | (49,135 | ) | (41,666 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from issuance of common stock | 4,888 | 24,388 | |||||
| Net cash provided by financing activities | 4,888 | 24,388 | |||||
| Effects of exchange rate changes on cash and cash equivalents | (945 | ) | (140 | ) | |||
| Net increase (decrease) in cash and cash equivalents | (27,909 | ) | 35,936 | ||||
| Cash and cash equivalents at beginning of period | 138,581 | 83,679 | |||||
| Cash and cash equivalents at end of period | $ 110,672 | $ | 119,615 | ||||
See accompanying notes to the condensed consolidated financial statements
5
MICROMUSE INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Basis of Presentation
The condensed consolidated financial statements are the unaudited historical financial statements of Micromuse Inc. and subsidiaries (the Company) and reflect all adjustments (consisting only of normal recurring adjustments) that, in the opinion of management, are necessary for a fair presentation of interim period results. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Companys Form 10-K as filed with the Securities and Exchange Commission on December 21, 2001. The September 30, 2001, consolidated balance sheet included herein was derived from audited financial statements, but does not include all disclosures, including notes, required by generally accepted accounting principles.
The results of operations for the current interim period are not necessarily indicative of results to be expected for the entire current year or other future interim periods.
Reclassifications
Certain
reclassifications, none of which affected net income, have been made to prior amounts to conform to the current period presentation.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from these estimates.
Cash Equivalents
The Company considers all highly liquid instruments with a
maturity at purchase of three months or less to be cash equivalents.
Shareholders Equity and Stock Split
All share and
per-share numbers herein reflect the 2 for 1 stock split of our common stock that occurred for stockholders of record on December 5, 2000.
6
MICROMUSE INC.
Per Share Data
Basic per share amounts are calculated using the weighted-average number of common shares outstanding during the period. Diluted per share amounts are calculated using the weighted-average number of common shares outstanding during the
period and, when dilutive, the weighted-average number of potential common shares from the exercise of outstanding options and warrants to purchase common stock using the treasury stock method. Excluded from the computation of net loss per share for
the three months ended June 30, 2002, was a warrant to acquire 54,321 shares of common stock at $5.42 per share, and options to acquire approximately 12.6 million shares of common stock, with a weighted average exercise price of $23.18 per share,
because their effect would be anti-dilutive. A reconciliation of the numerators and denominators used in the basic and diluted net income per share amounts follows (in thousands):
| Three months ended | Nine months ended | |||||||||||
| June 30, | June 30, | |||||||||||
| 2002 | 2001 | 2002 | 2001 | |||||||||
| Numerator for basic and diluted net income (loss) | $ | (979 | ) | $ | 7,863 | $ | 56 | $ | 20,293 | |||
| Denominator for basic net income (loss) per share weighted-average shares outstanding | 74,711 | 73,199 | 74,390 | 72,082 | ||||||||
| Dilutive effect of: | ||||||||||||
| Common stock options | - | 5,260 | 3,054 | 8,575 | ||||||||
| Warrant | - | - | 54 | - | ||||||||